Abstract
Although Niemann-Pick C1-Like 1 (NPC1L1) plays a key role in intestinal cholesterol absorption, regulating cholesterol metabolism and maintaining cholesterol metabolic homeostasis, the molecular mechanism of NPC1L1 in lipid-metabolism disorders leading to liver disease remains largely unknown. Previous studies have shown that NPC1L1 is related with the development of fatty liver. Therefore, we hypothesized that NPC1L1 plays an important role in lipid-metabolism disorders and liver disease by affecting the transcription of certain genes involved in lipid synthesis. To further elucidate the function of NPC1L1, especially in the liver, we used somatic-cell nuclear transfer to establish transgenic pigs that expressed human NPC1L1 in their livers. We investigated superoxide dismutase activities and the levels of free fatty acids and malondialdehyde, a biomarker of lipid peroxidation. Superoxide dismutase activities significantly decreased, and free fatty acid and malondialdehyde levels significantly increased in the NPC1L1 transgenic pigs, indicating that the overexpression of NPC1L1 in the liver resulted in severe lipid peroxidation. Our findings suggest that NPC1L1 plays an important role in lipid-metabolism disorders and liver disease.
Similar content being viewed by others
References
Al-Rawi NH (2011) Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res 8:22–28
Altmann SW, Davis HR Jr, Zhu LJ, Yao X, Hoos LM, Tetzloff G, Iyer SP, Maguire M, Golovko A, Zeng M et al (2004) Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303:1201–1204
Anzenbacherová E, Anzenbacher P, Svoboda Z, Ulrichová J, Kvetina J, Zoulová J, Perlík F, Martínková J (2003) Minipig as a model for drug metabolism in man: comparison of in vitro and in vivo metabolism of propafenone. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 147:155–159
Assady M, Farahnak A, Golestani A, Esharghian M (2011) Superoxide dismutase (SOD) enzyme activity assay in fasciola spp. parasites and liver tissue extract. Iran J Parasitol 6:17–22
Assy N, Grozovski M, Bersudsky I, Szvalb S, Hussein O (2006) Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease. World J Gastroenterol 12:4369–4376
Basaranoglu M, Basaranoglu G, Sentürk H (2013) From fatty liver to fibrosis: a tale of “second hit”. World J Gastroenterol 19:1158–1165
Bobard A, Hainault I, Ferré P, Foufelle F, Bossard P (2005) Differential regulation of sterol regulatory element-binding protein 1c transcriptional activity by insulin and liver X receptor during liver development. J Biol Chem 280:199–206
Catalá A (2012) Lipid peroxidation modifies the picture of membranes from the “Fluid Mosaic Model” to the “Lipid Whisker Model”. Biochimie 94:101–109
Chan J, Kushwaha RS, Vandeberg JF, Vandeberg JL (2008) Effect of ezetimibe on plasma cholesterol levels, cholesterol absorption, and secretion of biliary cholesterol in laboratory opossums with high and low responses to dietary cholesterol. Metabolism 57:1645–1654
Chen J, Jiang Y, Ma KY, Chen F, Chen ZY (2011) Microalga decreases plasma cholesterol by down-regulation of intestinal NPC1L1, hepatic LDL receptor, and HMG-CoA reductase. J Agric Food Chem 59:6790–6797
Davies JP, Scott C, Oishi K, Liapis A, Ioannou Y (2005) Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia. J Biol Chem 280:12710–12720
Davis HR Jr, Altmann SW (2009) Niemann-Pick C1 like 1 (NPC1L1) an intestinal sterol transporter. Biochim Biophys Acta 1791:679–683
Davis HR Jr, Hoos LM, Tetzloff G, Maguire M, Zhu LJ, Graziano MP, Altmann SW (2007) Deficiency of Niemann-Pick C1 like 1 prevents atherosclerosis in apoE−/− mice. Arterioscler Thromb Vasc Biol 27:841–849
Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M, Ishii H, Yoshida M (2007) Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett 581:5664–5670
Diraison F, Parton L, Ferré P, Foufelle F, Briscoe CP, Leclerc I, Rutter GA (2004) Over-expression of sterol-regulatory-element-binding protein-1c (SREBP1c) in rat pancreatic islets induces lipogenesis and decreases glucose-stimulated insulin release: modulation by 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Biochem J 378:769–778
Engelking LJ, Kuriyama H, Hammer RE, Horton JD, Brown MS, Goldstein JL, Liang G (2004) Overexpression of Insig-1 in the livers of transgenic mice inhibits SREBP processing and reduces insulin-stimulated lipogenesis. J Clin Investig 113:1168–1175
Enjoji M, Machida K, Kohjima M, Kato M, Kotoh K, Matsunaga K, Nakashima M, Nakamuta M (2010) NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease. Lipids Health Dis 9:29
Feldstein AE, Lopez R, Tamimi TA, Yerian L, Chung YM, Berk M, Zhang R, McIntyre TM, Hazen SL (2010) Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Lipid Res 51:3046–3054
Garcia-Calvo M, Lisnock J, Bull HG, Hawes BE, Burnett DA, Braun MP, Crona JH, Davis HR Jr, Dean DC, Detmers PA et al (2005) The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA 102:8132–8137
Griffin MJ, Sul HS (2004) Insulin regulation of fatty acid synthase gene transcription: roles of USF and SREBP-1c. IUBMB Life 56:595–600
Gulec B, Coskun K, Yigitler C, Yigit T, Aydin A, Oner K (2008) Ischemia-reperfusion injury in the liver during renal transplantation: does perfusion solution play any role? Transplant Proc 40:59–62
Ikeda S, Miyazaki H, Nakatani T, Kai Y, Kamei Y, Miura S, Tsuboyama-Kasaoka N, Ezaki O (2002) Up-regulation of SREBP-1c and lipogenic genes in skeletal muscles after exercise training. Biochem Biophys Res Commun 296:395–400
Jia L, Betters JL, Yu L (2011) Niemann-Pick C1-Like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport. Annu Rev Physiol 73:239–259
Joyce CW, Wagner EM, Basso F, Amar MJ, Freeman LA, Shamburek RD, Knapper CL, Syed J, Wu J, Vaisman BL et al (2006) ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis. J Biol Chem 281:33053–33065
Labonté ED, Camarota LM, Rojas JC, Jandacek RJ, Gilham DE, Davies JP, Ioannou YA, Tso P, Hui DY, Howles PN (2008) Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1−/− mice. Am J Physiol Gastrointest Liver Physiol 295:G776–G783
Lai L, Prather RS (2003) Production of cloned pigs by using somatic cells as donors. Cloning Stem Cells 5:233–241
Leamy AK, Egnatchik RA, Young JD (2013) Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. Prog Lipid Res 52:165–174
Leonarduzzi G, Arkan MC, Başağa H, Chiarpotto E, Sevanian A, Poli G (2000) Lipid oxidation products in cell signaling. Free Radic Biol Med 28:1370–1378
Levent G, Ali A, Ahmet A, Polat EC, Aytac C, Ayse E, Ahmet S (2006) Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. J Transl Med 4:25
Liu Y, Wang Z, Yin W, Li Q, Cai M, Zhang C, Xiao J, Hou H, Li H, Zu X (2007) Severe insulin resistance and moderate glomerulosclerosis in a minipig model induced by high-fat/high-sucrose/high-cholesterol diet. Exp Anim 56:11–20
Liu Y, Zeng BH, Shang HT, Cen YY, Wei H (2008) Bama miniature pigs (Sus scrofa domestica) as a model for drug evaluation for humans: comparison of in vitro metabolism and in vivo pharmacokinetics of lovastatin. Comp Med 58:580–587
Liu HB, Lv PR, He RG, Yang XG, Qin XE, Pan TB, Huang GY, Huang MR, Lu YQ, Lu SS et al (2010) Cloned Guangxi Bama minipig and its offspring have normal reproductive performance. Cell Reprogram 12:543–550
Miura S, Saku K (2008) Ezetimibe, a selective inhibitor of the transport of cholesterol. Intern Med 47:1165–1170
Musso G, Gambino R, Cassader M (2010) Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 11:430–445
Nam TG (2011) Lipid peroxidation and its toxicological implications. Toxicol Res 27:1–6
Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T et al (2010) Pathological aspects of lipid peroxidation. Free Radic Res 44:1125–1171
Nomura M, Ishii H, Kawakami A, Yoshida M (2009) Inhibition of hepatic Niemann-Pick C1-like 1 improves hepatic insulin resistance. Am J Physiol Endocrinol Metab 297:E1030–E1038
Poli G, Schaur RJ, Siems WG, Leonarduzzi G (2008) 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med Res Rev 28:569–631
Raghavan S, Subramaniyam G, Shanmugam N (2012) Proinflammatory effects of malondialdehyde in lymphocytes. J Leukoc Biol 92:1055–1067
Sané AT, Sinnett D, Delvin E, Bendayan M, Marcil V, Ménard D, Beaulieu JF, Levy E (2006) Localization and role of NPC1L1 in cholesterol absorption in human intestine. J Lipid Res 47:2112–2120
Santos JC, Valentim IB, de Araújo OR, Ataide TR, Goulart MO (2013) Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products. Int J Mol Sci 14:19846–19866
Sato Y, Suzuki R, Kobayashi M, Itagaki S, Hirano T, Noda T, Mizuno S, Sugawara M, Iseki K (2012) Involvement of cholesterol membrane transporter Niemann-Pick C1-like 1 in the intestinal absorption of lutein. J Pharm Pharm Sci 15:256–264
Shimano H (2000) Sterol regulatory element-binding protein-1 as a dominant transcription factor for gene regulation of lipogenic enzymes in the liver. Trends Cardiovasc Med 10:275–278
Shimano H (2001) Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 40:439–452
Shimano H (2002) Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitam Horm 65:167–194
Spirlandeli AL, Deminice R, Jordao AA (2014) Plasma malondialdehyde as biomarker of lipid peroxidation: effects of acute exercise. Int J Sports Med 35:14–18
Subramanian S, Goodspeed L, Wang S, Kim J, Zeng L, Ioannou GN, Haigh WG, Yeh MM, Kowdley KV, O’Brien KD, Pennathur S, Chait A (2011) Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. J Lipid Res 52:1626–1635
Sun Y, Jiang Q, Tian DY, Lin H, Li H, Han QY, Han W, Si CD, Hu SP et al (2011) Experimental infection of Bama miniature pigs with a highly virulent classical swine fever virus. Virol J 8:452
Surapneni KM, Chandrasada Gopan VS (2008) Lipid peroxidation and antioxidant status in patients with rheumatoid arthritis. Indian J Clin Biochem 23:41–44
Suryawanshi NP, Bhutey AK, Nagdeote AN, Jadhav AA, Manoorkar GS (2006) Study of lipid peroxide and lipid profile in diabetes mellitus. Indian J Clin Biochem 21:126–130
Takaki A, Kawai D, Yamamoto K (2013) Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int J Mol Sci 14:20704–20728
Tang W, Ma Y, Jia L, Ioannou YA, Davies JP, Yu L (2009) Genetic inactivation of NPC1L1 protects against sitosterolemia in mice lacking ABCG5/ABCG8. J Lipid Res 50:293–300
Temel RE, Tang W, Ma Y, Rudel LL, Willingham MC, Ioannou YA, Davies JP, Nilsson LM, Yu L (2007) Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe. J Clin Investig 117:1968–1978
Valasek MA, Repa JJ, Quan G, Dietschy JM, Turley SD (2008) Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters. Am J Physiol Gastrointest Liver Physiol 295:G813–G822
Vik-Mo AO, Fernø J, Skrede S, Steen VM (2009) Psychotropic drugs up-regulate the expression of cholesterol transport proteins including apoE in cultured human CNS- and liver cells. BMC Pharmacol 9:10
Vodicka P, Smetana K Jr, Dvoránková B, Emerick T, Xu YZ, Ourednik J, Ourednik V, Motlík J (2005) The miniature pig as an animal model in biomedical research. Ann N Y Acad Sci 1049:161–171
Wang S, Liu Y, Fang D, Shi S (2007) The miniature pig: a useful large animal model for dental and orofacial research. Oral Dis 13:530–537
Wang X, Sugimoto K, Fujisawa T, Shindo N, Minato S, Kamada Y, Hamano M, Ohishi M, Ikegami H, Rakugi H (2014) Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in fatty liver Shionogi mouse. Hepatol Res 44:102–113
Wong-Ekkabut J, Xu Z, Triampo W, Tang IM, Tieleman DP, Monticelli L (2007) Effect of lipid peroxidation on the properties of lipid bilayers: a molecular dynamics study. Biophys J 93:4225–4236
Yamagishi S, Nakamura K, Matsui T, Sato T, Takeuchi M (2006) Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver. Med Hypotheses 66:844–846
Yang SJ, Choi JM, Kim L, Kim BJ, Sohn JH, Kim WJ, Park SE, Rhee EJ, Lee WY, Oh KW et al (2011) Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes. Biochem Biophys Res Commun 407:153–157
Yang ZH, Miyahara H, Takeo J, Katayama M (2012) Diet high in fat and sucrose induces rapid onset of obesity-related metabolic syndrome partly through rapid response of genes involved in lipogenesis, insulin signalling and inflammation in mice. Diabetol Metab Syndr 4:32
Yu L, Hammer RE, Li-Hawkins J, Von Bergmann K, Lutjohann D, Cohen JC, Hobbs HH (2002a) Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci USA 99:16237–16242
Yu L, Li-Hawkins J, Hammer RE, Berge KE, Horton JD, Cohen JC, Hobbs HH (2002b) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Investig 110:671–680
Yu L, Bharadwaj S, Brown JM, Ma Y, Du W, Davis MA, Michaely P, Liu P, Willingham MC, Rudel LL (2006) Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake. J Biol Chem 281:6616–6624
Acknowledgments
This work was supported by Grants from the National Science and Technology Supporting Plan of China (NO. 2011BAI15B02), Changjiang Scholars and Innovative Research Team in University (PCSIRT, No. IRT1248) and National High-tech R&D Program of China (863 Program) (2012AA020603). We gratefully thank Pr. H. Ouyang, D. Pang, H. Wei and L. Yu for their expert assistance and suggestions.
Conflict of interest
The authors declare that there are no conflicts of interest associated with the publication of this article.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Chongli Xu and Yu Liu these authors have contributed equally to this paper.
Rights and permissions
About this article
Cite this article
Xu, C., Liu, Y., Gong, Y. et al. Overexpression of NPC1L1 in the livers of transgenic Bama miniature pigs accelerates lipid peroxidation. Genes Genom 37, 183–191 (2015). https://doi.org/10.1007/s13258-014-0235-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13258-014-0235-4